Our results suggest that inhibition of NF-κB and Wnt/β-catenin pathways or key cytokine signals along autocrine inflammatory forward-feedback loop after chemotherapy withdrawal will reduce tumor mass and secondary tumor initiation. The gene discussed is NFKB1; the disease is neoplasm.